Healthcare provider profile · identity verified

Jack D Vick, MD

Family Practice · FORT SUMNER, NM · NPI 1538242219

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	344	70
Atorvastatin Calcium	Atorvastatin Calcium	252	56
Lisinopril	Lisinopril	232	52
Gabapentin	Gabapentin	228	51
Amlodipine Besylate	Amlodipine Besylate	216	41
Metformin Hcl	Metformin Hcl	199	45
Losartan Potassium	Losartan Potassium	168	41
Omeprazole	Omeprazole	150	38
Metoprolol Succinate	Metoprolol Succinate	115	24
Meloxicam	Meloxicam	101	24
Tamsulosin Hcl	Tamsulosin Hcl	87	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	20
Potassium Chloride	Potassium Chloride	80	19
Albuterol Sulfate Hfa	Albuterol Sulfate	72	18
Escitalopram Oxalate	Escitalopram Oxalate	72	17
Duloxetine Hcl	Duloxetine Hcl	69	13
Pantoprazole Sodium	Pantoprazole Sodium	69	21
Baclofen	Baclofen	67	14
Simvastatin	Simvastatin	67	20
Allopurinol	Allopurinol	65	20
Trazodone Hcl	Trazodone Hcl	65	11
Clopidogrel	Clopidogrel Bisulfate	64	19
Carvedilol	Carvedilol	63	12
Hydrochlorothiazide	Hydrochlorothiazide	61	16
Famotidine	Famotidine	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Clonazepam	Clonazepam	54	suppressed
Dexamethasone	Dexamethasone	51	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	12
Ibu	Ibuprofen	50	11
Tramadol Hcl	Tramadol Hcl	50	11
Atenolol	Atenolol	49	suppressed
Glimepiride	Glimepiride	47	suppressed
Finasteride	Finasteride	46	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	11
Pioglitazone Hcl	Pioglitazone Hcl	44	11
Synthroid	Levothyroxine Sodium	42	13
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Alprazolam	Alprazolam	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	15
Eliquis	Apixaban	38	suppressed
Gemfibrozil	Gemfibrozil	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Meclizine Hcl	Meclizine Hcl	37	suppressed
Azithromycin	Azithromycin	36	33
Donepezil Hcl	Donepezil Hcl	36	suppressed
Lovastatin	Lovastatin	35	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Furosemide	Furosemide	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Sertraline Hcl	Sertraline Hcl	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Estradiol	Estradiol	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	15
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Methotrexate	Methotrexate Sodium	24	suppressed
Np Thyroid	Thyroid,pork	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Cephalexin	Cephalexin	21	17
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Prednisone	Prednisone	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Levofloxacin	Levofloxacin	20	11
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Glipizide	Glipizide	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Temazepam	Temazepam	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Indapamide	Indapamide	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	13
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Methadone Hcl	Methadone Hcl	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Valsartan	Valsartan	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluorouracil	Fluorouracil	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Rifampin	Rifampin	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error